FY2025 · ended Dec 31, 2025 · Revenue $875.26M, +82.4% YoY · Filed Mar 5, 2026
Nutex Health Inc. (NUTX) files with the SEC under industry code 7389, Services-Business Services, NEC. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $875.3 million and net income of $70.8 million. Free cash flow was $245.6 million. As of Sep 30, 2026 it held $249.9 million in cash and investments and $364.9 million in total debt.
Revenue (TTM)
$796.53M
-18.8% vs year-ago TTM
Net income (TTM)
$164.71M
+36.6% vs year-ago TTM
Operating cash flow (TTM)
$258.45M
+45.4% vs year-ago TTM
Free cash flow (TTM)
$248.10M
EPS (TTM)
$23.41
+40.6% vs year-ago TTM
Dividend per share
None
Shares outstanding
6.97M
+17.1% vs prior year
Net cash
$-115.00M
as of Sep 30, 2026
Operating margin
39.0%
FY 2026
Company profile
- Industry
- Services-Business Services, NEC (SIC 7389)
- Listed as
- NUTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Houston, TX
- SEC filer status
- Accelerated filer
- SEC CIK
- 1479681
- Former names
- Nutex Health, Inc. (until Feb 11, 2026); Clinigence Holdings, Inc. (until Mar 31, 2022); iGambit, Inc. (until Nov 13, 2019)
Other Services-Business Services, NEC companies
- Visa Inc. V
- Mastercard Inc MA
- Alibaba Group Holding Ltd BABA
- Accenture plc ACN
- Uber Technologies, Inc UBER
- PDD Holdings Inc. PDD
- Mercadolibre Inc MELI
- DoorDash, Inc. DASH
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $875.3M | $479.9M | $247.6M | $219.3M | $331.5M |
| Operating income | $275.6M | $130.7M | -$31.8M | -$406.6M | $170.3M |
| Net income | $70.8M | $52.1M | -$45.8M | -$424.8M | $132.6M |
| Diluted EPS | $10.48 | $9.69 | -$10.39 | -$100.36 | — |
| Operating cash flow | $248.1M | $23.2M | $1.3M | $50.6M | $173.4M |
| Free cash flow | $245.6M | $20.8M | — | $36.0M | — |
| Total assets | $918.5M | $655.3M | $398.2M | $431.8M | $394.7M |
| Total liabilities | $495.1M | $466.8M | $319.1M | $311.4M | $203.1M |
| Stockholders' equity | $329.4M | $132.4M | $61.5M | $95.9M | — |
| Cash and investments | $185.6M | $40.6M | $22.0M | $34.3M | $36.1M |
| Total debt | $350.7M | $336.7M | $272.4M | $264.6M | $102,499 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Sep 11, 2026 | Sep 10, 2026 |
| 8-K | Current report | Aug 31, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Other events
|
Aug 24, 2026 | Aug 24, 2026 |
| 8-K |
Current report
Other events
|
Aug 13, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
All 529 Nutex Health Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.